A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Prime Medicine Inc’s current trading price is -83.19% away from its 52-week high, while its distance from the 52-week low is 24.66%. The stock’s price range for this time frame has been between $1.12 and $8.27. The trading volume of the company’s shares in the Healthcare reached around 2.57 million for the day, which was evidently higher than the average daily volume of 1.31 million over the last three months.
In terms of market performance, Prime Medicine Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $8.27 on 05/21/24, while the lowest value was $1.12 on 04/09/25.
How Financial Performance Impacts Market Capitalization
Prime Medicine Inc (PRME) has experienced a quarterly decline of -51.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 182.31M and boasts a workforce of 214 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.5166, with a change in price of -1.5800. Similarly, Prime Medicine Inc recorded 1,254,967 in trading volume during the last 100 days, posting a change of -53.20%.
How PRME’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for PRME stands at 0.27. Similarly, the long-term debt-to-equity ratio is also 0.24.
PRME Stock Stochastic Average
Prime Medicine Inc’s raw stochastic average for the past 50 days is currently at 12.25%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 27.64%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 17.59% and 14.32%, respectively.
PRME Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The index has shown a price loss of -52.40% this year. Over the last six months, there has been a stronger performance of -64.90%. The price of PRME leaped by -30.85% during the last 30 days period. For the last 5-days stocks have improved 4.51%.
